Viral Vector/Plasmid Archives - amc

NHS Clinical Biotechnology Centre

NHS Clinical Biotechnology Centre

Viral Vector/Plasmid

NIHR Guy’s & St Thomas’ Biomedical Research Centre GMP Unit

NIHR Guy’s & St Thomas’ Biomedical Research Centre GMP Unit

Adherent Cells, Bulk Allogeneic Processes, Gene Modified Cells, Patient Specific Processes, Suspension Cells, T Cells, Tissue Processing, Viral Vector/Plasmid

Intercytex Ltd

Viral Vector/Plasmid

Centre for Cell Manufacturing Ireland (CCMI)

Centre for Cell Manufacturing Ireland (CCMI)

Adherent Cells, Bulk Allogeneic Processes, Gene Modified Cells, Patient Specific Processes, Suspension Cells, T Cells, Tissue Processing, Viral Vector/Plasmid

Newcastle University, Cellular Therapies Facility

Newcastle University, Cellular Therapies Facility

Adherent Cells, Bulk Allogeneic Processes, Gene Modified Cells, Patient Specific Processes, Suspension Cells, T Cells, Tissue Processing, Viral Vector/Plasmid

Rayne Cell Therapy Suite

Rayne Cell Therapy Suite

Viral Vector/Plasmid

John Goldman Centre for Cellular Therapy

John Goldman Centre for Cellular Therapy

Viral Vector/Plasmid

Paul O’Gorman Laboratory of Cellular Therapy

Paul O’Gorman Laboratory of Cellular Therapy

Viral Vector/Plasmid

Clinical Biomanufacturing Facility, University of Oxford

Clinical Biomanufacturing Facility, University of Oxford

Viral Vector/Plasmid

Cellular Therapeutics Ltd

Cellular Therapeutics Ltd

Adherent Cells, Bulk Allogeneic Processes, Gene Modified Cells, Patient Specific Processes, Suspension Cells, T Cells, Tissue Processing, Viral Vector/Plasmid